Venkataraman, director of Sarcoma Pathways and physician at Dana-Farber Cancer Institute, in Boston, explained that treatment ...

For managed care organizations and health systems, the recommendations strongly advocated highly selective use of NGS. Routine, nonselective NGS for all sarcoma patients is not justified. Instead, ...

It's feared people diagnosed with a rare type of cancer called Sarcoma could face journeys of hundreds of miles for treatment ...

A Cornwall surfer who had a whole arm amputated after contracting a rare form of cancer, fears anyone who suffers from the ...

Soft tissue sarcomas (STS) are rare malignant tumors arising from connective tissues such as muscle, fat, and blood vessels, ...

Dr. Vinayak Venkataraman, medical oncologist and director of Sarcoma Pathways at Dana-Farber Cancer Institute in Boston, ...

Intensity Therapeutics, Inc. ("Intensity" or "the Company") (Nasdaq: INTS), a late-stage clinical biotechnology company focused on the discovery and development of novel intratumoral cancer therapies ...

October 2025 proved to be a significant month for the oncology landscape, marked by a wave of key regulatory decisions from ...

Kindi Barrie has faced challenge after challenge in her 16 years. Recently, her right foot was amputated in hopes of stopping ...

Intensity Therapeutics’ stock has risen nearly 400% after its oncology candidate showed high overall survival (OS) and ...

Cardinal Robert McElroy plans to be back at work in Washington two weeks after his surgery, scheduled for Nov. 13.

Mel Leverton was reassured for six years that her neck and shoulder pain was simply a trapped nerve caused by a collapsed vertebrae. She underwent scans, consultations and was even offered surgery.